181 related articles for article (PubMed ID: 23499631)
1. Effect of Wenxin Keli and quinidine to suppress arrhythmogenesis in an experimental model of Brugada syndrome.
Minoura Y; Panama BK; Nesterenko VV; Betzenhauser M; Barajas-Martínez H; Hu D; Di Diego JM; Antzelevitch C
Heart Rhythm; 2013 Jul; 10(7):1054-62. PubMed ID: 23499631
[TBL] [Abstract][Full Text] [Related]
2. Cellular mechanisms underlying the effects of milrinone and cilostazol to suppress arrhythmogenesis associated with Brugada syndrome.
Szél T; Koncz I; Antzelevitch C
Heart Rhythm; 2013 Nov; 10(11):1720-7. PubMed ID: 23911896
[TBL] [Abstract][Full Text] [Related]
3. Ionic and cellular mechanisms underlying the development of acquired Brugada syndrome in patients treated with antidepressants.
Minoura Y; Di Diego JM; Barajas-Martínez H; Zygmunt AC; Hu D; Sicouri S; Antzelevitch C
J Cardiovasc Electrophysiol; 2012 Apr; 23(4):423-32. PubMed ID: 22034916
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms underlying the development of the electrocardiographic and arrhythmic manifestations of early repolarization syndrome.
Koncz I; Gurabi Z; Patocskai B; Panama BK; Szél T; Hu D; Barajas-Martínez H; Antzelevitch C
J Mol Cell Cardiol; 2014 Mar; 68():20-8. PubMed ID: 24378566
[TBL] [Abstract][Full Text] [Related]
5. Cellular and ionic mechanisms underlying the effects of cilostazol, milrinone, and isoproterenol to suppress arrhythmogenesis in an experimental model of early repolarization syndrome.
Patocskai B; Barajas-Martinez H; Hu D; Gurabi Z; Koncz I; Antzelevitch C
Heart Rhythm; 2016 Jun; 13(6):1326-34. PubMed ID: 26820510
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms Underlying Epicardial Radiofrequency Ablation to Suppress Arrhythmogenesis in Experimental Models of Brugada Syndrome.
Patocskai B; Yoon N; Antzelevitch C
JACC Clin Electrophysiol; 2017 Apr; 3(4):353-363. PubMed ID: 28948234
[TBL] [Abstract][Full Text] [Related]
7. Cellular mechanism underlying hypothermia-induced ventricular tachycardia/ventricular fibrillation in the setting of early repolarization and the protective effect of quinidine, cilostazol, and milrinone.
Gurabi Z; Koncz I; Patocskai B; Nesterenko VV; Antzelevitch C
Circ Arrhythm Electrophysiol; 2014 Feb; 7(1):134-42. PubMed ID: 24429494
[TBL] [Abstract][Full Text] [Related]
8. Acacetin suppresses the electrocardiographic and arrhythmic manifestations of the J wave syndromes.
Di Diego JM; Patocskai B; Barajas-Martinez H; Borbáth V; Ackerman MJ; Burashnikov A; Clatot J; Li GR; Robinson VM; Hu D; Antzelevitch C
PLoS One; 2020; 15(11):e0242747. PubMed ID: 33232375
[TBL] [Abstract][Full Text] [Related]
9. Why Is Only Type 1 Electrocardiogram Diagnostic of Brugada Syndrome? Mechanistic Insights From Computer Modeling.
Zhang Z; Chen PS; Weiss JN; Qu Z
Circ Arrhythm Electrophysiol; 2022 Jan; 15(1):e010365. PubMed ID: 34963310
[TBL] [Abstract][Full Text] [Related]
10. A transient outward potassium current activator recapitulates the electrocardiographic manifestations of Brugada syndrome.
Calloe K; Cordeiro JM; Di Diego JM; Hansen RS; Grunnet M; Olesen SP; Antzelevitch C
Cardiovasc Res; 2009 Mar; 81(4):686-94. PubMed ID: 19073629
[TBL] [Abstract][Full Text] [Related]
11. Wenxin Keli attenuates ischemia-induced ventricular arrhythmias in rats: Involvement of L‑type calcium and transient outward potassium currents.
Wang X; Wang X; Gu Y; Wang T; Huang C
Mol Med Rep; 2013 Feb; 7(2):519-24. PubMed ID: 23174802
[TBL] [Abstract][Full Text] [Related]
12. Phase 2 Re-Entry Without I
Zhang Z; Brugada P; Weiss JN; Qu Z
JACC Clin Electrophysiol; 2023 Dec; 9(12):2459-2474. PubMed ID: 37831035
[TBL] [Abstract][Full Text] [Related]
13. Atrial-selective inhibition of sodium-channel current by Wenxin Keli is effective in suppressing atrial fibrillation.
Burashnikov A; Petroski A; Hu D; Barajas-Martinez H; Antzelevitch C
Heart Rhythm; 2012 Jan; 9(1):125-31. PubMed ID: 21884675
[TBL] [Abstract][Full Text] [Related]
14. Abnormal repolarization as the basis for late potentials and fractionated electrograms recorded from epicardium in experimental models of Brugada syndrome.
Szél T; Antzelevitch C
J Am Coll Cardiol; 2014 May; 63(19):2037-45. PubMed ID: 24657694
[TBL] [Abstract][Full Text] [Related]
15. Differences in arrhythmogenicity between the canine right ventricular outflow tract and anteroinferior right ventricle in a model of Brugada syndrome.
Morita H; Zipes DP; Morita ST; Wu J
Heart Rhythm; 2007 Jan; 4(1):66-74. PubMed ID: 17198993
[TBL] [Abstract][Full Text] [Related]
16. Antiarrhythmic Effect of Artemisinin in an Ex-vivo Model of Brugada Syndrome Induced by NS5806.
Jeong HK; Hong SN; Yoon N; Lee KH; Park HW; Cho JG
Korean Circ J; 2023 Apr; 53(4):239-250. PubMed ID: 37161682
[TBL] [Abstract][Full Text] [Related]
17. Cellular basis for arrhythmogenesis in an experimental model of the SQT1 form of the short QT syndrome.
Patel C; Antzelevitch C
Heart Rhythm; 2008 Apr; 5(4):585-90. PubMed ID: 18362027
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms underlying the antiarrhythmic effect of ARumenamide-787 in experimental models of the J wave syndromes and hypothermia.
Di Diego JM; Barajas-Martinez H; Cox R; Robinson VM; Jung J; Fouda M; Patocskai B; Abdelsayed M; Ruben PC; Antzelevitch C
PLoS One; 2023; 18(5):e0281977. PubMed ID: 37159454
[TBL] [Abstract][Full Text] [Related]
19. Effects of flecainide and quinidine on arrhythmogenic properties of Scn5a+/- murine hearts modelling the Brugada syndrome.
Stokoe KS; Balasubramaniam R; Goddard CA; Colledge WH; Grace AA; Huang CL
J Physiol; 2007 May; 581(Pt 1):255-75. PubMed ID: 17303635
[TBL] [Abstract][Full Text] [Related]
20. Wenxin Keli suppresses ventricular triggered arrhythmias via selective inhibition of late sodium current.
Xue X; Guo D; Sun H; Wang D; Li J; Liu T; Yang L; Shu J; Yan GX
Pacing Clin Electrophysiol; 2013 Jun; 36(6):732-40. PubMed ID: 23438075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
